Navigation Links
Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress

y. This study provides the first clinical evidence for Nasalfent as an effective, acceptable and well-tolerated treatment and is also the first study to report clinically meaningful relief of breakthrough cancer pain at five minutes using a non-injected route of administration. A nasally-delivered product that offers more rapid onset of pain relief than that seen with existing oral therapies would help reduce the burden of breakthrough cancer pain for patients and their caregivers."

Dr Mark Watling, Medical Director of Archimedes said: "The data presented at today's EAPC congress highlights the potential of Nasalfent to address a significant market and medical need. With an international Phase III trial programme now underway, Archimedes is generating an extensive body of data to support regulatory filings in both the US and Europe with the aim of bringing a vital therapy to patients with breakthrough cancer pain."

Nasalfent is a trade mark of Archimedes and are registered as CTM, and US Registered Trademarks and in certain other jurisdictions.

Enquiries Archimedes Pharma: Michael Clark, +44 118 931 5050, +44 7973 111683 Citigate Dewe Rogerson: Chris Gardner, +44 (0)207 638 9571 For more information on Archimedes, visit: www.archimedespharma.com

Notes to Editors

About Archimedes Pharma Archimedes is a European specialty pharmaceutical company with an established commercial organisation in the UK, Ireland, France and Germany and a portfolio of products marketed to specialist prescribers. Archimedes' products include Gliadel, a biodegradable wafer impregnated with an anti-cancer drug, carmustine, for high-grade glioma; Zomorph, an oral sustained release morphine product for cancer pain; Nozinan, a neuroleptic which possesses anti-emetic, antihistamine and anti-adrenaline activity and used to treat patients with cancer; and Pabrinex, a high potency formulation of vitamin
'"/>




Page: 1 2 3

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:4/24/2015)... 24, 2015 Introduction ... indication-specific planning tools for radiosurgery/SBRT   ... aimed at enhancing the workflow for difficult to ... in 2013 - comes full circle with the ... These new Elements enable on-the-fly generation of consistent ...
(Date:4/24/2015)... , April 24, 2015 Hi-Tech ... that such was not the product of reliable scientific ... a reliable basis for allegations of adulteration. The ... on a false premise, or misguided hope, that ... these studies are contradicted by multiple other studies ...
(Date:4/24/2015)... Hospira, Inc. (NYSE: HSP ... therapies, spoke about the importance of extrapolation in bringing ... (EGA) annual European Biosimilars Group conference in ... the publication of a pivotal white paper titled, ... of biosimilars." Speaking at the EGA ...
Breaking Medicine Technology:Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7
... January 5, 2012 Orthopedic Implants are medical ... injured or troubled joints. Bone is the basic element of ... and assists in movement. Humans commonly suffer from physical fractures, ... or humerus. Treatment of these fractures often requires surgery to ...
... SAN DIEGO, Jan. 5, 2012 Cardium Therapeutics (NYSE Amex: ... entered into its first international agreement for the commercialization ... Cardium entered into a marketing and distribution agreement with ... Korea, for the commercialization of Excellagen Formulated Fibrillar Collagen ...
Cached Medicine Technology:Narang Medical Introduces NET Multifix Nails: Same Nail That Can be Used for Right and Left Legs 2Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 2Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 3Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 4Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 5Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea 6
(Date:4/26/2015)... India Network Foundation, a non-profit organization in the ... the Asian Indian community in the United States and ... two decades. The India News Network Digest of 1990s ... world with the latest news items from India, the ... Forum Digest, edited and contributed by Sheela Murthy, helped ...
(Date:4/26/2015)... Petersburg, FL (PRWEB) April 26, 2015 ... Diego, California. The city is one which is synonymous with ... Tourism, international trade, and education are major economic influencers in ... Producers of the dynamic talk show are pleased to announce ... on Sunday, April 26 at 3:00 PM PDT. Tune in ...
(Date:4/25/2015)... The National League for Nursing's Advancing Care ... prepare nurses to provide high quality, culturally sensitive care ... a new report by the John A. Hartford Foundation, ... The project began in 2007 as a pilot at ... Elaine Tagliareni, EdD, RN, CNE, FAAN, professor and Independence ...
(Date:4/25/2015)... In observance of World Malaria Day, today ... Pledge, a two-year pledge by the United Nations Foundation’s ... one million bednets by 2016. This ambitious $10 million ... to protect children, refugees, and families displaced by conflict ... been a large surge in refugee families displaced by ...
(Date:4/25/2015)... York, New York (PRWEB) April 25, 2015 ... ) established for vaginal mesh lawsuits filed against ... the U.S. District Court, Southern District of West ... 9th, a Scheduling Conference was convened that day, ... Plaintiffs’ Master Long Form Complaint. The Order directed ...
Breaking Medicine News(10 mins):Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 2Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 3Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4
... Health Common User Interface will help, increase clinician efficiency ... ... Wash., Sept. 10 Healthcare,developers will be able to increase ... User Interface (CUI),available today from Microsoft Corp. The guidance and ...
... School of Medicine have developed a molecular probe that ... is to use the probe to improve the diagnosis ... probe,s main ingredient is a molecule that labels active ... cancerous cells. The molecule is normally invisible to the ...
... PAINWeek 2007 Said Most Patients ... VEGAS, Sept. 8 In addition to reporting a ... surveyed,during PAINWeek 2007 said treating pain will improve insomnia ... Nearly 98 percent of those polled said they believed ...
... Sets Better Ability to Improve Patient Care, ... St.,Francis Medical Center have reached a tentative agreement ... that will increase their ability to,advocate for improved ... of a qualified and skilled staff. The ...
... 2007 Inc. 500, LAS VEGAS, Sept. 7 Inc. ... Inc. 500 list of the fastest-growing,private companies in the U.S. ... that same category, achieved a record three year sales growth ... "If you want to find out which companies are going ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... treatment of venous reflux disease, today,announced the resignation ... President, Finance & Administration, to be effective October ... begun a search for a,new chief financial officer. ...
Cached Medicine News:Health News:Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit 2Health News:Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit 3Health News:Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit 4Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 2Health News:Molecular probe 'paints' cancer cells in living animals, Stanford researchers find 3Health News:Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007 2Health News:Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007 3Health News:Workers Win Contract at St. Francis Medical Center 2Health News:Inc. Magazine Reveals Its 26th Annual List of America's 500 Fastest-Growing Private Companies 2Health News:Inc. Magazine Reveals Its 26th Annual List of America's 500 Fastest-Growing Private Companies 3
... The Chalam Flat is ... nerve neurotomy and induction of ... also useful for macula whole ... removal of tractional epiretinal membranes. ...
... 1.5x is specifically designed ... peeling in macular hole ... sheathotomy and macularepiretinal membrane ... and other situations warranting ...
... ACS lenses offer the high resolution, high ... original clariVits. The simple two part design ... integrity during surgery. Simply autoclave, add saline ... lock together for use. (ACS) AutoClave Sterilizable ...
... offers high resolution by far surpassing ... in stereopsis, brilliance and clarity, detailed ... in diabetics, membrane peeling extending to ... Sterilizable Lenses The ACS Vitrectomy Lenses ...
Medicine Products: